![4-{[4-Phenyl-6-(trifluoromethyl)pyrimidin-2-yl]-thio}butanoic acid - chemical structure image](https://media.scbt.com/product/4-4-phenyl-6-trifluoromethyl-pyrimidin-2-yl-thiobutanoic-acid-structure_23_12_b_231298.jpg)
![4-{[4-Phenyl-6-(trifluoromethyl)pyrimidin-2-yl]-thio}butanoic acid - chemical structure image](https://media.scbt.com/product/4-4-phenyl-6-trifluoromethyl-pyrimidin-2-yl-thiobutanoic-acid-structure_23_12_t_231298.jpg "Molecular structure of 4-{[4-Phenyl-6-(trifluoromethyl)pyrimidin-2-yl]-thio}butanoic acid")
4-{[4-Phenyl-6-(trifluoromethyl)pyrimidin-2-yl]-thio}butanoic acid
QUICK LINKS
Cdk1/5 Inhibitor is utilized in the field of cell biology, particularly in studies focused on cell cycle regulation and cellular proliferation. Cdk1/5 Inhibitor is instrumental in investigating the roles of cyclin-dependent kinases (CDKs) 1 and 5 in various cellular processes, including mitosis and neuronal functions. Some may use Cdk1/5 Inhibitor to the mechanisms by which these kinases influence cell division and development, which is for understanding cancer biology and neurodegenerative effects. The inhibition of CDK1 and CDK5 by Cdk1/5 Inhibitor allows for detailed analysis of their downstream effects, providing insights into potential targets for novel interventions. Cdk1/5 Inhibitor is in studies aiming to understand the interplay between cell cycle progression and cellular stress responses, enhancing the knowledge base for developing strategies to manipulate these pathways.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4-{[4-Phenyl-6-(trifluoromethyl)pyrimidin-2-yl]-thio}butanoic acid, 500 mg | sc-315599 | 500 mg | $270.00 |